Family · Pharmaceutical analytical standards
Moxifloxacin
A fluoroquinolone antibiotic approved in 1999, active against many respiratory bacteria; it is also used in eye drops and in drug-resistant tuberculosis. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Quinolones were born by chance: the first one, nalidixic acid, was found in 1962 among the by-products of the synthesis of an antimalarial, chloroquine.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
